As the level of tumor markers and gene mutations of KRAS/NRAS/PIK3CA/BRAF are detected, it can be found that the concentrations of CEA, CA24-2, and CA19-9 of patients with CRC are quite higher. This evidence concerns the gene BRAF and colorectal carcinoma.